Cytotoxicity of various bisphosphonates on human umbilical cord-derived stem cells
Sharma, C.G.D. (2014) Cytotoxicity of various bisphosphonates on human umbilical cord-derived stem cells. In: Abstracts from the 54th Annual Scientific Meeting of the International Association for Dental Research Australian & New Zealand Division. 193641. pp. 154-155. From: 54th Annual Scientific Meeting of the International Association for Dental Research Australian & New Zealand Division, 28 September – 1 October 2014, Brisbane, QLD, Australia.
|
PDF (Abstract Only)
- Published Version
Download (307kB) | Preview |
Abstract
Objective: Bisphosphonates (BPs) are a group of drugs primarily used to prevent bone resorption in a variety of clinical situations including osteoporosis, Paget’s disease and invasive malignancy- related bone resorption. BP use has been associated with osteonecrosis of the jaw (BRONJ and the biological mechanisms leading to this condition are not fully understood. This in vitro study aimed to evaluate the effect of different classes of BPs (non-nitrogen containing clodronate, and the nitrogen containing BPs alendronate and zoledronate) on human umbilical cord-derived stem cells (UCSCs).
Method: UCSCs were cultured in-vitro with clodronate, alendronate and zoledronate at 0.25μM, 0.5μM, 1μM, 2μM and 3μM in culture media for 10 days and an Alamar Blue assay was conducted to assess the effects of the drugs on cell proliferation. To assess the cytotoxicity of the drugs, live/dead staining was used at 24 and 48 hours’ time point. Further, to evaluate the effects of these drugs on cell migration, scratch wound healing assays were conducted at 6 and 24 hours.
Result: All of the BPs tested were found to negatively affect UCSC cell proliferation with the lowest effect shown by clodronate (0.25 μM) and the highest with zoledronate at 5 μM concentration. Live/dead staining also revealed a similar trend with the high potency drug zoledronate causing the highest cytotoxicity. Further, the scratch wound healing assay showed that zoledronate significantly inhibited cellular migration at both time points compared to minimal or no effect of clodronate at any concentration.
Conclusion: The non-nitrogen containing BPs are less cytotoxic and have minimum inhibition of proliferation and migration of UCSC as compared to the more potent nitrogen-containing BPs alendronate and zoledronate
Item ID: | 70991 |
---|---|
Item Type: | Conference Item (Abstract / Summary) |
Keywords: | Stem Cells; Bisphosphonates; Cytotoxicity; Zoledronic acid |
Related URLs: | |
Date Deposited: | 06 Dec 2021 23:35 |
FoR Codes: | 32 BIOMEDICAL AND CLINICAL SCIENCES > 3203 Dentistry > 320399 Dentistry not elsewhere classified @ 50% 32 BIOMEDICAL AND CLINICAL SCIENCES > 3203 Dentistry > 320303 Dental therapeutics, pharmacology and toxicology @ 50% |
SEO Codes: | 20 HEALTH > 2001 Clinical health > 200102 Efficacy of medications @ 100% |
Downloads: |
Total: 31 Last 12 Months: 4 |
More Statistics |